Anti-diuresis in the management of daytime urinary incontinence

Urinary incontinence and lower urinary tract dysfunction, whilst not life threatening conditions, remain an important cause of morbidity in women and are responsible for significant impairment of quality of life. Drug therapy is often used to treat women who complain of urgency and urge incontinence and has an emerging role in the management of stress urinary incontinence. However, bothersome side effects are known to affect compliance and therefore compromise efficacy, making longterm drug therapy unpopular. The principle aim of this thesis is to assess the role of antidiuresis in women complaining of daytime urinary incontinence and also to examine its role as a ‘designer therapy’ which women can choose to use as, or when, required. In addition both the patients’ and clinicians’ attitudes towards treatment have been studied to clarify the meaning of ‘cure’, and to determine treatment acceptability, overall outcome and patient satisfaction. In the first study the patients’ concept of cure is explored as well as their expectations regarding treatment and outcome. The second study examines cure from the clinician’s perspective in addition to reviewing outcome measures in the clinical and research settings. Finally in the third study the use of desmopressin in women complaining of daytime urinary incontinence is reported.

[1]  W. Steers,et al.  Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. , 2004, American journal of obstetrics and gynecology.

[2]  C. Kelleher,et al.  How much is enough and who says so? , 2004, BJOG : an international journal of obstetrics and gynaecology.

[3]  L. Cardozo,et al.  What Do Women Want?: Interpretation of the Concept of Cure , 2003 .

[4]  P. Herbison,et al.  Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review , 2003, BMJ : British Medical Journal.

[5]  P. Hilton.  Trials of surgery for stress incontinence—thoughts on the ‘Humpty Dumpty principle’ , 2002, BJOG : an international journal of obstetrics and gynaecology.

[6]  P. Hilton,et al.  Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence , 2002, BMJ : British Medical Journal.

[7]  W. Steers,et al.  Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? , 2002, American journal of obstetrics and gynecology.

[8]  P. Abrams,et al.  Efficacy of desmopressin in the treatment of nocturia: a double‐blind placebo‐controlled study in men , 2002, BJU international.

[9]  A. Victor,et al.  Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction , 2001, Acta obstetricia et gynecologica Scandinavica.

[10]  S Hunskaar,et al.  A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag. , 2000, Journal of clinical epidemiology.

[11]  J. Donovan,et al.  Nocturnal incontinence in women: a hidden problem. , 2000, The Journal of urology.

[12]  J. Donovan.  Measuring the impact of nocturia on quality of life , 1999, BJU international.

[13]  C. Bengtsson,et al.  The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population , 1999, Acta obstetricia et gynecologica Scandinavica.

[14]  R C Slack,et al.  What is a community? , 1998, Public health.

[15]  J. Duckett,et al.  A new questionnaire to assess the quality of life of urinary incontinent women , 1998, British journal of obstetrics and gynaecology.

[16]  J. Blaivas.  Outcome measures for urinary incontinence. , 1998, Urology.

[17]  N. Black,et al.  Impact of surgery for stress incontinence on morbidity: cohort study , 1997, BMJ.

[18]  J. Duckett,et al.  A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance , 1997, British journal of obstetrics and gynaecology.

[19]  L. Cardozo,et al.  A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance , 1997, British journal of obstetrics and gynaecology.

[20]  H. Ruder,et al.  Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing. , 1997, European journal of pediatrics.

[21]  J. Herbert,et al.  Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. , 1996, Archives of neurology.

[22]  A. Leung,et al.  Hyponatremia in patients with nocturnal enuresis treated with DDAVP , 1996, European Journal of Pediatrics.

[23]  H. Kamphuisen,et al.  Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  M. Brown,et al.  Analysis of the pattern of urine loss in women with incontinence as measured by weighing perineal pads. , 1986, British journal of urology.

[25]  K. Hertogs,et al.  The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[26]  T. Gerstenberg,et al.  Placebo--the drug of choice in female motor urge incontinence? , 1983, British journal of urology.

[27]  P. Worth.  Assessment and treatment of urinary incontinence , 1982, The Lancet.

[28]  Edward G. Carmines,et al.  Reliability and Validity Assessment , 1979 .

[29]  A. Victor,et al.  Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction , 1998, Neurourology and urodynamics.

[30]  J. Djurhuus,et al.  Standardization of outcome studies in patients with lower urinary tract dysfunction: A report on general principles from the standardisation committee of the international continence society , 1998, Neurourology and urodynamics.

[31]  P. Herbison.  Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: recommendations of the Urodynamic Society. , 1998, Neurourology and urodynamics.

[32]  N. Resnick,et al.  Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: Recommendations of the Urodynamic Society , 1997, Neurourology and urodynamics.

[33]  D. Mitrović,et al.  [Drug therapy of nocturnal enuresis]. , 1992, Medicinski pregled.